Protective effects of low-frequency magnetic fields on cardiomyocytes from ischemia reperfusion injury via ROS and NO/ONOO-.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 3839120)

Published in Oxid Med Cell Longev on November 07, 2013

Authors

Sai Ma1, Zhengxun Zhang, Fu Yi, Yabin Wang, Xiaotian Zhang, Xiujuan Li, Yuan Yuan, Feng Cao

Author Affiliations

1: Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shannxi 710032, China.

Articles cited by this

Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13

Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev (2008) 5.52

Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol (2001) 2.82

Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation (2002) 2.14

Occurrence of oxidative stress during reperfusion of the human heart. Circulation (1990) 1.53

Fundamentals of reperfusion injury for the clinical cardiologist. Circulation (2002) 1.49

The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther (2011) 1.46

Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart. Mol Cell Biochem (2009) 1.38

Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism. Diabetes (2013) 1.28

Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization. Eur Heart J (2010) 1.23

Nitric oxide and cardioprotection during ischemia-reperfusion. Heart Fail Rev (2002) 1.16

Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury. Cardiovasc Res (1999) 1.04

Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction. Circ Cardiovasc Interv (2012) 0.94

Adverse balance of nitric oxide/peroxynitrite in the dysfunctional endothelium can be reversed by statins. J Cardiovasc Pharmacol (2007) 0.94

Effects of 50 Hz extremely low frequency magnetic field on the morphology and function of boar spermatozoa capacitated in vitro. Theriogenology (2006) 0.93

Involvement of mitochondrial activity in mediating ELF-EMF stimulatory effect on human sperm motility. Bioelectromagnetics (2011) 0.90

Endothelial cell response to pulsed electromagnetic fields: stimulation of growth rate and angiogenesis in vitro. J Cell Physiol (1988) 0.88

Oxidative stress and apoptosis in relation to exposure to magnetic field. Cell Biochem Biophys (2011) 0.84

Protective effect of low frequency low energy pulsing electromagnetic fields on acute experimental myocardial infarcts in rats. Bioelectromagnetics (1999) 0.83

Effects of extremely low frequency magnetic field on the parameters of oxidative stress in heart. J Physiol Pharmacol (2010) 0.83

Ischemic preconditioning preserves mitochondrial membrane potential and limits reactive oxygen species production. J Surg Res (2012) 0.82

Enhanced cell survival and diminished apoptotic response to simulated ischemia-reperfusion in H9c2 cells by magnetic field preconditioning. Apoptosis (2012) 0.80

Articles by these authors

Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet (2006) 4.35

Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol (2011) 4.09

HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell (2011) 3.89

Signal transduction by vascular endothelial growth factor receptors. Biochem J (2011) 3.47

Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc Natl Acad Sci U S A (2006) 3.09

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature (2013) 3.00

MicroRNA, mRNA, and protein expression link development and aging in human and macaque brain. Genome Res (2010) 2.44

Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle (2009) 2.30

Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc Natl Acad Sci U S A (2008) 2.25

Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation (2008) 2.22

Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation (2007) 2.21

Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol (2013) 2.16

Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy. J Gastroenterol (2015) 2.01

Oxidized LDL downregulates ATP-binding cassette transporter-1 in human vascular endothelial cells via inhibiting liver X receptor (LXR). Cardiovasc Res (2005) 1.99

Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium. Stem Cells (2007) 1.93

Multiple effects of silymarin on the hepatitis C virus lifecycle. Hepatology (2010) 1.92

Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells (2008) 1.90

Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin Infect Dis (2011) 1.87

Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas. Nat Genet (2013) 1.80

Quantum dot imaging for embryonic stem cells. BMC Biotechnol (2007) 1.78

Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron (2012) 1.78

Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis. Eur Heart J (2013) 1.77

Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ (2010) 1.64

Vascular endothelial growth factors and receptors: anti-angiogenic therapy in the treatment of cancer. Mol Aspects Med (2011) 1.58

Survivin: a novel player in insulin cardioprotection against myocardial ischemia/reperfusion injury. J Mol Cell Cardiol (2010) 1.58

Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging. Stem Cells (2009) 1.58

Positron emission tomography imaging of conditional gene activation in the heart. J Mol Cell Cardiol (2007) 1.56

Perilipin 5 improves hepatic lipotoxicity by inhibiting lipolysis. Hepatology (2015) 1.55

The Fun30 nucleosome remodeller promotes resection of DNA double-strand break ends. Nature (2012) 1.54

Change in high-sensitive C-reactive protein during abdominal aortic aneurysm formation. J Hypertens (2009) 1.54

Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. FASEB J (2005) 1.52

Pathological cardiac hypertrophy alters intracellular targeting of phosphodiesterase type 5 from nitric oxide synthase-3 to natriuretic peptide signaling. Circulation (2012) 1.51

In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation. Stem Cells Dev (2008) 1.46

Experimental Cerenkov luminescence tomography of the mouse model with SPECT imaging validation. Opt Express (2010) 1.45

Relationship between particle mass and mobility for diesel exhaust particles. Environ Sci Technol (2003) 1.45

Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in cancer: a meta-analysis. Gene (2012) 1.44

The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J Immunol (2010) 1.44

Helicobacter pylori detection by polymerase chain reaction in pediatric gastritis. J Pediatr Gastroenterol Nutr (2012) 1.43

Early prediction of organ failure under the revised Atlanta classification. Turk J Gastroenterol (2016) 1.43

The presence of the Y-chromosome, not the absence of the second X-chromosome, alters the mRNA levels stored in the fully grown XY mouse oocyte. PLoS One (2012) 1.42

Can insulin resistance be reversed by insulin therapy? Med Hypotheses (2008) 1.41

Quantitative analysis of hemoglobin content in polymeric nanoparticles as blood substitutes using Fourier transform infrared spectroscopy. J Mater Sci Mater Med (2010) 1.41

Tetracarboxylate-based Co(II), Ni(II) and Cu(II) three-dimensional coordination polymers: syntheses, structures and magnetic properties. Dalton Trans (2010) 1.39

Molecular pharmacognosy: a new borderline discipline. Nat Prod Commun (2009) 1.39

Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity. Cancer Res (2008) 1.39

Hydrodynamics of biological aggregates of different sludge ages: an insight into the mass transport mechanisms of bioaggregates. Environ Sci Technol (2003) 1.38

Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization. Blood (2008) 1.38

VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO J (2010) 1.37

18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. J Nucl Med (2006) 1.37

Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan. Biomaterials (2009) 1.35

Intergenic and repeat transcription in human, chimpanzee and macaque brains measured by RNA-Seq. PLoS Comput Biol (2010) 1.33

Design and testing of a microfluidic biochip for cytokine enzyme-linked immunosorbent assay. Biomicrofluidics (2009) 1.33

VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. J Exp Med (2012) 1.31

The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials (2012) 1.29

Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies. Hum Mol Genet (2012) 1.28

Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism. Diabetes (2013) 1.28

Extension of cortical synaptic development distinguishes humans from chimpanzees and macaques. Genome Res (2012) 1.27

Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats. PLoS One (2012) 1.27

Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation. Physiol Genomics (2006) 1.26

PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2. Eur J Nucl Med Mol Imaging (2012) 1.25

Proteomic analysis of reporter genes for molecular imaging of transplanted embryonic stem cells. Proteomics (2006) 1.24

Widespread splicing changes in human brain development and aging. Mol Syst Biol (2013) 1.23

Heavy doping and band engineering by potassium to improve the thermoelectric figure of merit in p-type PbTe, PbSe, and PbTe(1-y)Se(y). J Am Chem Soc (2012) 1.23

Molecular imaging of human embryonic stem cells: keeping an eye on differentiation, tumorigenicity and immunogenicity. Cell Cycle (2006) 1.19

Gastric cancer incidence and mortality in Zhuanghe, China, between 2005 and 2010. World J Gastroenterol (2012) 1.19

Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of posaconazole (Noxafil). Drug Metab Dispos (2004) 1.18

The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes. PLoS Pathog (2013) 1.18

Risk of gastric cancer is associated with the MUC1 568 A/G polymorphism. Int J Oncol (2009) 1.18

Genetic modification of embryonic stem cells with VEGF enhances cell survival and improves cardiac function. Cloning Stem Cells (2007) 1.17

Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse. Am J Physiol Heart Circ Physiol (2006) 1.15

VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation. Nat Commun (2013) 1.13

Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways. Basic Res Cardiol (2013) 1.12

BM-map: Bayesian mapping of multireads for next-generation sequencing data. Biometrics (2011) 1.11

Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR. FASEB J (2008) 1.11

Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy. Cardiovasc Diabetol (2011) 1.11

Fhb, a novel factor H-binding surface protein, contributes to the antiphagocytic ability and virulence of Streptococcus suis. Infect Immun (2012) 1.11

Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Med Oncol (2013) 1.11

A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse. Brain Struct Funct (2011) 1.09

Recovery from DNA damage-induced G2 arrest requires actin-binding protein filamin-A/actin-binding protein 280. J Biol Chem (2003) 1.09

LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling. Hypertension (2009) 1.08

Identification of inappropriately reprogrammed genes by large-scale transcriptome analysis of individual cloned mouse blastocysts. PLoS One (2010) 1.08

β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity. Antiviral Res (2013) 1.07

Mutations in TRPV4 cause an inherited arthropathy of hands and feet. Nat Genet (2011) 1.07

Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia). Drug Metab Dispos (2004) 1.07

Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting. J Cell Sci (2009) 1.07

mTORC1 and mTORC2 play different roles in the functional survival of transplanted adipose-derived stromal cells in hind limb ischemic mice via regulating inflammation in vivo. Stem Cells (2013) 1.07

Evolution of phosphorylation-dependent regulation of activation-induced cytidine deaminase. Mol Cell (2008) 1.05

Characterization of human liver enzymes involved in the biotransformation of boceprevir, a hepatitis C virus protease inhibitor. Drug Metab Dispos (2010) 1.05

Prospective cohort study of comprehensive prevention to gastric cancer. World J Gastroenterol (2003) 1.04

Inositol pyrophosphates mediate the effects of aging on bone marrow mesenchymal stem cells by inhibiting Akt signaling. Stem Cell Res Ther (2014) 1.04

Breast mass segmentation in mammography using plane fitting and dynamic programming. Acad Radiol (2009) 1.03

Analysis of specialized DNA polymerases expression in human gliomas: association with prognostic significance. Neuro Oncol (2010) 1.03

Clinical hurdles for the transplantation of cardiomyocytes derived from human embryonic stem cells: role of molecular imaging. Curr Opin Biotechnol (2006) 1.02

Doping dependence of spin excitations and its correlations with high-temperature superconductivity in iron pnictides. Nat Commun (2013) 1.02

TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury. Basic Res Cardiol (2014) 1.01

Drug-target interaction prediction: databases, web servers and computational models. Brief Bioinform (2015) 1.01